1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Estrogen receptors and inflammation in colorectal cancer. Role in prognosis and therapeutic opportunities.
- 2016
- Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic Pain
- 2014
- Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study
- Deficiency of ER beta and prostate tumorigenesis in FGF8b transgenic mice
- 2008
- Haplotypes of the estrogen receptor beta gene and breast cancer risk
-
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
Sonestedt, Emily LU
; Borgquist, Signe
LU
; Ericson, Ulrika
LU
; Gullberg, Bo
LU
; Olsson, Håkan
LU
; Adlercreutz, Herman
; Landberg, Göran
LU
and Wirfält, Elisabet
LU
(2008)
In Cancer Epidemiology Biomarkers & Prevention
17(11).
p.51-3241
Mark
- Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist
- Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist
- 2007
-
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
Gruvberger, Sofia LU ; Bendahl, Pär-Ola LU ; Saal, Lao H LU
; Laakso, Mervi
; Hegardt, Cecilia
LU
; Edén, Patrik
LU
; Peterson, Carsten
LU
; Malmström, Per
LU
; Isola, Jorma
LU
and Borg, Åke
LU
, et al.
(2007)
In Clinical Cancer Research
13(7).
p.1987-1994
Mark
- 2005
- Estrogen receptor alpha and beta in breast cancer - gene expression profiles and clinical implications